Lamivudine
May 16, 2012 at 12:41 | Source: Moneycontrol.com
Sep 20, 2011 at 20:49 | Source: PTI
Aug 11, 2009 at 12:04 | Source: Moneycontrol.com
Dec 22, 2008 at 13:33
Sep 08, 2008 at 16:01
Dec 06, 2007 at 17:08
Photos »
/ 
News across the web »
May 17, 2012 at 17:55 | Source: The Hindu BusinessLine
Nov 01, 2011 at 05:26 | Source: NDTV Profit
Interact & exchange stock tips & market info »
Drug firm Lupin today said it has received tentative approval from the...
12.47 PM Nov 1st 2011
Mylan Inc today said its Indian subsidiary Matrix Laboratories had rec...
1.29 PM Sep 21st 2011
Related News »
Background Suppression of hepatitis B virus (HBV) DNA is more potent, and occurrence of resistant strain is rare with entecavir than lamivudine, but whether these merits result in a more favourable outcome in HBV-related decompensated cirrhosis ...
May 24, 2012 at 10:07 | Source: Medscape News
Aurobindo Pharma Limited has pocketed final authorization from the US Food and Drug Administration (FDA) to produce and sell lamivudine and zidovudine tabs USP 150/300mg (ANDA 202418). Hyderabad-based pharma major said that it is ready to launch the ...
May 19, 2012 at 05:12 | Source: Top News India
Background Combination antiviral therapy holds the promise of increasing response rates while decreasing antiviral resistance, but has yet to be shown to be beneficial or necessary in chronic hepatitis B. Aim To evaluate the benefit of ...
May 8, 2012 at 10:04 | Source: Medscape News
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch. Lamivudine & Zidovudine ...
May 16, 2012 at 07:17 | Source: equitybulls.com
Aurobindo Pharma Limited, Hyderabad-based pharma major, has received final approval from the US FDA to manufacture and market lamivudine and zidovudine tablets USP 150/300mg (ANDA 202418) and is ready for launch. Lamivudine and zidovudine tablets USP 150 ...
May 16, 2012 at 07:17 | Source: pharmabiz.com
(RTTNews) - Pharmaceutical company Lupin Ltd. announced that its subsidiary Lupin Pharmaceuticals inc. had obtained final approval from US FDA for its Lamivudine and Zidovudine tablets, 150mg/ 300mg. The Mumbai-based company said it already commenced ...
May 16, 2012 at 05:59 | Source: RTT News
Hyderabad-based pharmaceutical company Aurobindo Pharma limited (APL) on Wednesday stated that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lamivudine and Zidovudine tablets. According to APL ...
May 16, 2012 at 08:36 | Source: Business Standard
Crude estimates of numbers of public sector patients on treatment in each quarter were calculated according to lamivudine (3TC, Epivir) sales figures from Aspen Pharmacare, which supplied 80% of lamivudine to the public sector until recently. While they ...
May 18, 2012 at 04:37 | Source: Aidsmap
Lupin has received approval and subsequently launched generic Lamivudine and Zidovudine Tablets (Brand name: Combivir; market size: US$275mn; Dosage: 150mg, 300mg; Indication: Antiretroviral) in the US. The company’s launch follows expiry of Teva’s six ...
May 16, 2012 at 11:21 | Source: Stock Markets Review
Truvada should not be co-administered with any other antiretroviral agents for HIV that contain emtricitabine or tenofovir disoproxil fumarate, nor should it be co-administered with products containing lamivudine. Do not administer with Hepsera.
May 11, 2012 at 11:27 | Source: Phramalive.com